SC 13G 1 clnh052421formsch13g.htm SC 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. __) *

 

CLINIGENCE HOLDINGS, INC.

(Name of Issuer)

 

Common stock, par value $0.001 per share

(Title of Class of Securities)

 

18727D105

(CUSIP Number)

 

February 26, 2021

(Date of Event Which Requires Filing of This Statement)

 

Check the appropriate box to designate the Rule pursuant to which this Schedule is filed:

 

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

Continued on following pages

Page 1 of 4

 

 1 

 

 

(1) NAME OF REPORTING PERSONS

 

DOMINIS-EMBREE AHA INVESTOR, LLC

 

(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐

(b) ☐

 

(3) SEC USE ONLY

 

 

(4) CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

 

(5) SOLE VOTING POWER – 6,473,483 shares of common stock

 

(6) SHARED VOTING POWER – 0 shares of common stock

 

(7) SOLE DISPOSITIVE POWER – 6,473,483 shares of common stock

 

(8) SHARED DISPOSITIVE POWER – 0 shares of common stock

 

(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

6,473,483 shares of common stock

 

(10) CHECK BOX IF AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

16.49%

 

(12) TYPE OF REPORTING PERSON

 

OO

 

 2 

 

 

ITEM 1(a). NAME OF ISSUER

 

CLINIGENCE HOLDINGS, INC.

 

ITEM 1(b). ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES

 

501 1st Avenue, Suite 901

St. Petersburg, Florida 33701

 

ITEM 2(a). NAME OF PERSON FILING.

 

This Schedule 13G is being filed by Dominis-Embree AHA Investor, LLC, a Delaware limited liability company (the “Reporting Person”).

 

ITEM 2(b). ADDRESS OR PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE.

 

The address of the Reporting Person is 4747 Williams Drive, Georgetown, Texas 78633.

 

ITEM 2(c). CITIZENSHIP.

 

Delaware.

 

ITEM 2(d). TITLE OF CLASS OF SECURITIES:

 

Common stock.

 

ITEM 2(e). CUSIP No.

 

18727D105

 

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B), OR 13D-2(B):

 

Not applicable.

 

ITEM 4. OWNERSHIP

  

(a) Amount beneficially owned: 6,473,483 shares of common stock.

 

(b) Percentage of class: 16.49%

 

(c) Number of shares as to which the person has:

 

(i) Sole power to vote or to direct the vote: 6,473,483 shares.

 

(ii) Shared power to vote or to direct the vote: 0 shares.

 

(iii) Sole power to dispose or to direct the disposition of: 6,473,483 shares.

 

(iv) Shared power to dispose or to direct the disposition of: 0 shares.

 

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

 

Not applicable.

 

ITEM 6. OWNERSHIP OF MORE THAN 5 PERCENT ON BEHALF OF ANOTHER PERSON.

 

Not applicable.

 

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

 

Not applicable.

 

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

 

Not applicable.

 

ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

 

Not applicable.

 

ITEM 10. CERTIFICATIONS.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, or other than activities solely in connection with a nomination under §240.14a-11.

 

 3 

 

 

SIGNATURE

 

After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

Dated: May 24, 2021

 

DOMINIS-EMBREE AHA INVESTOR, LLC

 

By: Dominis-Embree AHA GP, LLC

By its Managing Member

 

FG Capital Management LLC

 

By: /s/ Bruce M. Arinaga

Bruce M. Arinaga, Manager

 

 4